| Product Code: ETC10939435 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Vaccine Contract Development and Manufacturing Organization Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Vaccine Contract Development and Manufacturing Organization Market - Industry Life Cycle |
3.4 Sweden Vaccine Contract Development and Manufacturing Organization Market - Porter's Five Forces |
3.5 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Scale of Operation, 2021 & 2031F |
3.8 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Client Type, 2021 & 2031F |
3.9 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Technology Platform, 2021 & 2031F |
4 Sweden Vaccine Contract Development and Manufacturing Organization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for vaccines in Sweden due to rising prevalence of infectious diseases and government initiatives promoting vaccination. |
4.2.2 Growth in research and development activities in the pharmaceutical industry, leading to increased outsourcing of vaccine development and manufacturing. |
4.2.3 Technological advancements in vaccine production processes, driving the need for specialized contract development and manufacturing organizations. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and quality standards in vaccine manufacturing, leading to higher compliance costs for contract development and manufacturing organizations. |
4.3.2 Intense competition in the market, leading to pricing pressures and margin constraints for players in the industry. |
5 Sweden Vaccine Contract Development and Manufacturing Organization Market Trends |
6 Sweden Vaccine Contract Development and Manufacturing Organization Market, By Types |
6.1 Sweden Vaccine Contract Development and Manufacturing Organization Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Development Services, 2021 - 2031F |
6.1.4 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Manufacturing Services, 2021 - 2031F |
6.1.5 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By FillFinish Services, 2021 - 2031F |
6.2 Sweden Vaccine Contract Development and Manufacturing Organization Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2.3 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Viral Vector Vaccines, 2021 - 2031F |
6.2.4 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Subunit Vaccines, 2021 - 2031F |
6.3 Sweden Vaccine Contract Development and Manufacturing Organization Market, By Scale of Operation |
6.3.1 Overview and Analysis |
6.3.2 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Clinical Scale, 2021 - 2031F |
6.3.3 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Commercial Scale, 2021 - 2031F |
6.3.4 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Pilot Scale, 2021 - 2031F |
6.4 Sweden Vaccine Contract Development and Manufacturing Organization Market, By Client Type |
6.4.1 Overview and Analysis |
6.4.2 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.4.4 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Government Agencies, 2021 - 2031F |
6.5 Sweden Vaccine Contract Development and Manufacturing Organization Market, By Technology Platform |
6.5.1 Overview and Analysis |
6.5.2 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By CellBased Platforms, 2021 - 2031F |
6.5.3 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By Recombinant DNA Technology, 2021 - 2031F |
6.5.4 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenues & Volume, By LiveAttenuated Platforms, 2021 - 2031F |
7 Sweden Vaccine Contract Development and Manufacturing Organization Market Import-Export Trade Statistics |
7.1 Sweden Vaccine Contract Development and Manufacturing Organization Market Export to Major Countries |
7.2 Sweden Vaccine Contract Development and Manufacturing Organization Market Imports from Major Countries |
8 Sweden Vaccine Contract Development and Manufacturing Organization Market Key Performance Indicators |
8.1 Percentage of revenue derived from new vaccine development projects. |
8.2 Number of strategic partnerships and collaborations formed with pharmaceutical companies. |
8.3 Rate of successful technology transfer and scale-up of vaccine manufacturing processes. |
9 Sweden Vaccine Contract Development and Manufacturing Organization Market - Opportunity Assessment |
9.1 Sweden Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Sweden Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.3 Sweden Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Scale of Operation, 2021 & 2031F |
9.4 Sweden Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Client Type, 2021 & 2031F |
9.5 Sweden Vaccine Contract Development and Manufacturing Organization Market Opportunity Assessment, By Technology Platform, 2021 & 2031F |
10 Sweden Vaccine Contract Development and Manufacturing Organization Market - Competitive Landscape |
10.1 Sweden Vaccine Contract Development and Manufacturing Organization Market Revenue Share, By Companies, 2024 |
10.2 Sweden Vaccine Contract Development and Manufacturing Organization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here